We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 287

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

The perils and promise of 3D printing: are DIY life sciences in your future?

  • Drinker Biddle & Reath LLP
  • -
  • USA
  • -
  • May 13 2013

With news that 3D printing (without question one of the coolest technologies to come down the road in quite some time) can be used to produce guns

Ninth Circuit to consider impact of trial court error in admitting expert testimony

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 4 2013

In related cases that could have implications for intellectual property, consumer safety and complex litigation where resolution of the dispute

News bytes - March 7, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 7 2013

The U.S. Patent and Trademark Office (USPTO) seeks public comments by May 3, 2013, on "information requirements related to civil actions and claims

Top 10 steps global life sciences companies should take in 2013

  • Sidley Austin LLP
  • -
  • USA
  • -
  • March 1 2013

Engage in US budget and deficit reduction process. As governments, including the US and China, search for the means to fund priorities or reduce

Abuse-deterrent opioids guidance clarifies intellectual property issues, but leaves some questions unanswered

  • Arnall Golden Gregory LLP
  • -
  • USA
  • -
  • February 19 2013

On January 9, 2013, the U.S. Food and Drug Administration issued its much anticipated draft guidance document to assist industry in developing new

BLG Monthly Update

  • Borden Ladner Gervais LLP
  • -
  • Argentina, Australia, Canada, United Kingdom, USA
  • -
  • December 19 2012

The BLG Monthly Update is a digest of recent developments in the law which Neil Guthrie, our National Director of Research, thinks you will find

Bring-your-own device policies present special challenges for the health care sector

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • October 2 2012

The use of employee-owned devices in the business setting often referred to as “bring-your-own-device” or “BYOD” presents data security challenges for all businesses

Conduct of fundamental research can still implicate U.S. export control laws

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • August 30 2012

Most research institutions are aware that an exemption for "fundamental research" exists under U.S. export control laws

A call for more collaboration in industrial biotech

  • Kaye Scholer LLP
  • -
  • USA
  • -
  • August 28 2012

The growing shortage and rising price of fossil energy has increased interest in finding economically attractive replacements that draw on biotechnology